Arrhythmias in Cardiac Sarcoidosis: Management and Prognostic Implications

Area of Science:

• Cardiology
• Immunology
• Electrophysiology

Background:

• Cardiac sarcoidosis (CS) presents with diverse arrhythmias, including ventricular arrhythmias, conduction disease, and atrial fibrillation.
• These arrhythmic manifestations significantly impact prognosis and long-term survival.
• Management is complex, involving both arrhythmia control and suppression of myocardial inflammation.

Purpose of the Study:

• To review the management strategies for arrhythmic manifestations in cardiac sarcoidosis.
• To discuss risk stratification methods for sudden cardiac death in CS patients.

Main Methods:

• Literature review focusing on cardiac sarcoidosis, arrhythmias, and sudden cardiac death.
• Synthesis of current guidelines and research on CS management.

Main Results:

• Arrhythmic complications are a primary cause of mortality in CS.
• Effective management involves tailored antiarrhythmic therapy and immunosuppression.
• Risk stratification tools aid in identifying patients at high risk for sudden cardiac death.

Conclusions:

• Comprehensive management of CS arrhythmias and inflammation is crucial for improving outcomes.
• Risk stratification is essential for timely intervention and prevention of sudden cardiac death.
• Further research is needed to optimize therapeutic strategies for cardiac sarcoidosis.